Leap Therapeutics Inc. (LPTX), focused on developing targeted and immuno-oncology therapeutics, has several upcoming clinical trial events to watch in the next few months.
The company's lead drug candidate is DKN-01, being developed for esophagogastric, gynecologic, and colorectal cancers. Also in the pipeline is FL-501, a humanized monoclonal antibody targeting the growth and differentiation factor 15 (GDF-15) protein, in preclinical development.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.